Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CIC Corporation was a Japanese holding company and the primary ownership vehicle for Dr. Yoshinori Shirono, the founder of Ci:z Holdings Co., Ltd. The company was central to the operations of Ci:z Holdings, a prominent Japanese firm specializing in the marketing, development, and distribution of dermocosmetic and skincare products under brands such as Dr.Ci:Labo. In 2019, CIC Corporation was acquired by Johnson & Johnson as part of a larger transaction to take full ownership of Ci:z Holdings. This acquisition allowed Johnson & Johnson to integrate a leading portfolio of science-based skincare products into its global consumer health business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CIC Corporation.